ARENA PHARMACEUTICALS INC 4
4 · ARENA PHARMACEUTICALS INC · Filed Jul 3, 2014
Insider Transaction Report
Form 4
LIEF JACK
DirectorChairman, President and CEO
Transactions
- Sale
Common Stock
2014-07-01$5.85/sh−223,525$1,308,582→ 361,039 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.80 and $5.95 per share, inclusive. The reporting person undertakes to provide Arena Pharmaceuticals, Inc., any security holder of Arena Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The amount includes shares purchased under Arena's employee stock purchase plan prior to the reported transaction.